OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to retinyl palmitate (CAS RN 79-81-2), retinyl acetate (CAS RN 127-47-9), Retinyl propionate (CAS RN 7069-42-3), retinyl dodecanoate (CAS RN 1259-24-1), retinyl retinoate (CAS RN 15498-86-9), retinol oleate (CAS RN 631-88-9), retinyl stearate (CAS RN 631-87-8), retinyl myristate (CAS RN 1181-93-7), retinyl linoleate (CAS RN 631-89-0), retinyl heptanoate (CAS RN 88641-44-5), and retinol phosphate (CAS RN 53859-19-1), retinol laurate (CAS RN Not Available), Retinyl pivalate (CAS RN 20559-05-1), retinylphosphate galactose (CAS RN 35795-65-4). retinol (vitamin A) is a yellow, fat-soluble, antioxidant vitamin that is important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain provitamin A carotenoids. Vitamin A is indicated for the treatment and prophylaxis of vitamin A deficiency. Retinol and its esters, including retinyl palmitate, are used in cosmetic products such as face and eye creams, body lotions, sun lotions, lip products, and baby creams.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Retinol, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.